Results 121 to 130 of about 287,615 (160)

Development of a new device to measure arterial stiffness and its reliability, and its potential to detect history of cardiovascular events in patients with chronic kidney disease. [PDF]

Nagoya J Med Sci
Takeda Y, Kato S, Wang J, Ando M, Matsumoto T, Yoshida Y, Masuda H, Maruyama S.   +7 more
europepmc   +1 more source

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors. [PDF]

Front Cardiovasc Med
Umanath K, Dwyer JP, Mentz RJ.
europepmc   +1 more source

The Spatial Representation of Self-Referential Negative Events. [PDF]

Behav Sci (Basel)
Conson M, Cecere R, Puini CMC, Panico F, Zappullo I, Sagliano L, Trojano L.   +6 more
europepmc   +1 more source

Disease-Associated Mutations Impact DNA Methyltransferase 1 Function through Dynamic Allosteric Effects and Solvent Exposure. [PDF]

J Chem Theory Comput
Xie S, Yildiz CB, Ruggerone P, Zuo K, Zimmer-Bensch G, Carloni P.   +5 more
europepmc   +1 more source

Sepsis prognosis in the emergency department: assessment of shock indices, SOFA, qSOFA, and lactate. [PDF]

Int J Emerg Med
Akpinar G, Bulut SP, Ozsemerci HA, Kose A, Doğan S, Basıbuyuk AE, Yılmaz AS, Hamitoglu M.   +7 more
europepmc   +1 more source

Thoracic aortic disease in young patients: from genetics to management. [PDF]

Front Cardiovasc Med
Fatehi Hassanabad A, McKenzie MP, Keir M, Fedak PWM.   +3 more
europepmc   +1 more source

Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment. [PDF]

Transl Cancer Res
Carmona-Bayonas A, Jimenez-Fonseca P.
europepmc   +1 more source

Strengthening evidence-based practices in assessment and treatment planning for substance use disorder: an evaluation of a Swedish training program for social services. [PDF]

Front Psychiatry
Lundgren LM, Jemberie WB, Sandlund M, Nyström S, Blom Nilsson M, Grahn R.   +5 more
europepmc   +1 more source